Tybourne Capital Management (Hk) LTD Olema Pharmaceuticals, Inc. Transaction History

Tybourne Capital Management (Hk) LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 27, 2021	SELL	$22.96 - $30.13 $5.51 Million - $7.23 Million	-239,996 Closed	0 $0
Q2 2021 Jul 22, 2021	SELL	$21.15 - $36.14 $423,084 - $722,944	-20,004 Reduced 7.69%	239,996 $6.72 Million
Q4 2020 Feb 11, 2021	BUY	$37.09 - $54.5 $9.64 Million - $14.2 Million	260,000 New	260,000 $12.5 Million

136

58.7M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $393M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Tybourne Capital Management (Hk) LTD, based on Form 13F filings with the SEC.

Stay updated on Tybourne Capital Management (Hk) LTD with notifications on news.